Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Endothelium, inflammation, and diabetes.

Paresh Dandona¹

¹SUNY Buffalo, Kaleida, Health, 3 Gates Circle, Buffalo, NY 14209, USA. pdandona@kaleidahealth.org

Current Diabetes Reports

|March 20, 2003

Summary

Insulin and thiazolidinediones (TZDs) demonstrate anti-inflammatory and antiatherogenic properties by stimulating nitric oxide release. These findings offer new insights into treating atherosclerosis in insulin-resistant states like obesity and type 2 diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis.

Diabetes & metabolism·2025

Same author

Diabetes surpasses obesity as a risk factor for low serum testosterone level.

Diabetology & metabolic syndrome·2024

Same author

Glucose ingestion does not lower testosterone concentrations in men on testosterone therapy.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2024

Same author

Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon.

World journal of diabetes·2024

Same author

More on Semaglutide in Early Type 1 Diabetes. Reply.

The New England journal of medicine·2024

Same author

Vasoactive mediators of hypertension in obesity.

American journal of physiology. Endocrinology and metabolism·2023

Area of Science:

Vascular biology
Endocrinology
Pharmacology

Background:

The endothelium plays a crucial role in vascular integrity, producing vasodilators like nitric oxide (NO) and prostacyclin.
These molecules inhibit platelet aggregation, are antithrombotic, and possess anti-inflammatory and antiatherogenic properties.
Insulin resistance, common in obesity and type 2 diabetes, significantly increases the risk of atherosclerosis, coronary heart disease, and stroke.

Purpose of the Study:

To investigate the potential antiatherogenic effects of insulin and thiazolidinediones (TZDs).
To explore the role of endothelial nitric oxide (NO) release in the context of insulin resistance and atherosclerosis.
To understand the implications for treating atherosclerosis in insulin-resistant populations.

Main Methods:

Review of recent findings on endothelial function and insulin signaling.
Analysis of the vasodilatory, antiplatelet, and anti-inflammatory effects of insulin and TZDs.
Correlation of these effects with the pathogenesis of atherosclerosis in insulin-resistant states.

Main Results:

Insulin stimulates endothelial nitric oxide (NO) release, exhibiting vasodilatory, antiplatelet, and anti-inflammatory effects.
Thiazolidinediones (TZDs), including troglitazone and rosiglitazone, show similar anti-inflammatory actions.
These actions suggest potential antiatherogenic benefits for both insulin and TZDs.

Conclusions:

Insulin and TZDs may offer a rational approach to preventing and treating atherosclerosis in insulin-resistant states.
Understanding these endothelial mechanisms is vital for managing cardiovascular complications in obesity and type 2 diabetes.
Further research into these pathways could lead to novel therapeutic strategies for atherosclerosis.

Related Experiment Videos